Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 2
2007 2
2008 4
2009 5
2011 2
2012 2
2013 1
2014 1
2015 5
2016 6
2017 9
2018 9
2019 8
2020 11
2021 6
2022 12
2023 17
2024 12

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
OX40L Inhibition Suppresses KLH-driven Immune Responses in Healthy Volunteers: A Randomized Controlled Trial Demonstrating Proof-of-Pharmacology for KY1005.
Saghari M, Gal P, Gilbert S, Yateman M, Porter-Brown B, Brennan N, Quaratino S, Wilson R, Grievink HW, Klaassen ES, Bergmann KR, Burggraaf J, van Doorn MBA, Powell J, Moerland M, Rissmann R. Saghari M, et al. Among authors: rissmann r. Clin Pharmacol Ther. 2022 May;111(5):1121-1132. doi: 10.1002/cpt.2539. Epub 2022 Mar 1. Clin Pharmacol Ther. 2022. PMID: 35092305 Free PMC article. Clinical Trial.
Mirabegron.
Goulooze SC, Cohen AF, Rissmann R. Goulooze SC, et al. Among authors: rissmann r. Br J Clin Pharmacol. 2015 Oct;80(4):762-4. doi: 10.1111/bcp.12647. Epub 2015 Jun 5. Br J Clin Pharmacol. 2015. PMID: 25819590 Free PMC article.
Bedaquiline.
Goulooze SC, Cohen AF, Rissmann R. Goulooze SC, et al. Among authors: rissmann r. Br J Clin Pharmacol. 2015 Aug;80(2):182-4. doi: 10.1111/bcp.12613. Epub 2015 Jul 2. Br J Clin Pharmacol. 2015. PMID: 25702772 Free PMC article. No abstract available.
Tolvaptan.
Dubois EA, Rissmann R, Cohen AF. Dubois EA, et al. Among authors: rissmann r. Br J Clin Pharmacol. 2012 Jan;73(1):9-11. doi: 10.1111/j.1365-2125.2011.04029.x. Br J Clin Pharmacol. 2012. PMID: 21623874 Free PMC article. No abstract available.
Denosumab.
Dubois EA, Rissmann R, Cohen AF. Dubois EA, et al. Among authors: rissmann r. Br J Clin Pharmacol. 2011 Jun;71(6):804-6. doi: 10.1111/j.1365-2125.2011.03969.x. Br J Clin Pharmacol. 2011. PMID: 21434974 Free PMC article. No abstract available.
Olaparib.
Goulooze SC, Cohen AF, Rissmann R. Goulooze SC, et al. Among authors: rissmann r. Br J Clin Pharmacol. 2016 Jan;81(1):171-3. doi: 10.1111/bcp.12761. Epub 2015 Oct 24. Br J Clin Pharmacol. 2016. PMID: 26344419 Free PMC article.
Sofosbuvir and daclatasvir.
Hessel MH, Cohen AF, Rissmann R. Hessel MH, et al. Among authors: rissmann r. Br J Clin Pharmacol. 2016 Sep;82(3):878-9. doi: 10.1111/bcp.13011. Epub 2016 Jun 12. Br J Clin Pharmacol. 2016. PMID: 27198488 Free PMC article. No abstract available.
Lomitapide.
Goulooze SC, Cohen AF, Rissmann R. Goulooze SC, et al. Among authors: rissmann r. Br J Clin Pharmacol. 2015 Aug;80(2):179-81. doi: 10.1111/bcp.12612. Epub 2015 Jul 2. Br J Clin Pharmacol. 2015. PMID: 25702706 Free PMC article. No abstract available.
Vemurafenib/dabrafenib and trametinib.
Rissmann R, Hessel MH, Cohen AF. Rissmann R, et al. Br J Clin Pharmacol. 2015 Oct;80(4):765-7. doi: 10.1111/bcp.12651. Epub 2015 Jun 11. Br J Clin Pharmacol. 2015. PMID: 25847075 Free PMC article. No abstract available.
Complement Activation in Inflammatory Skin Diseases.
Giang J, Seelen MAJ, van Doorn MBA, Rissmann R, Prens EP, Damman J. Giang J, et al. Among authors: rissmann r. Front Immunol. 2018 Apr 16;9:639. doi: 10.3389/fimmu.2018.00639. eCollection 2018. Front Immunol. 2018. PMID: 29713318 Free PMC article. Review.
91 results